NOVO NORDISK INC. for NOVO NORDISK INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
HR 8 American Taxpayer Relief Act (R&D tax credit) of 2012 (R&D credit)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL New | — |
Trade (domestic/foreign) TRD
EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property); Trans-Pacific Partnership (TPP); intellectual property
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL New | — |
Health Issues HCR
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), Prevention and Public Health Fund, AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S 539 National Diabetes Clinical Care Commission Act of 2013; human growth / rare disorders awareness; H.R. 8 American Taxpayer Relief Act (Special Diabetes Program reauthorization); gestational diabetes; diabetes disparities; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL New | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL New | — |
Budget/Appropriations BUD
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8 FY14 Senate Budget Resolution; H Con Res. 25 House Budget Resolution; Modernizing cost estimates with respect to preventive health legislation (CBO scoring); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL New | — |
Pharmacy PHA
Issues regarding Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and discussion draft on serialization (track and trace); S.622 -- Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 for amendments that would impact human drug user fees; issues regarding biosimilars; 340B
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRICIA BROOKS | — |
| MICHAEL MAWBY | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| SHAYLAH NUNN | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVO A/S | Denmark | Denmark | 25.5% | — |
| NOVO NORDISK FONDEN (FOUNDATION) | Denmark | Denmark | 25.5% | — |
| NOVO NORDISK A/S | Denmark | Denmark | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.